http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0133070-A3
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6459 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| filingDate | 1984-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1987-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0133070-A3 |
| titleOfInvention | Process for the production of a tissue plasminogen activator, and the activator obtained by this process |
| abstract | The present invention relates to a production processntion of a tissue plasminogen activator.n n n This process is characterized by cultivation and incunbation of a particular category of cells, namelynembryonic tissue cells, and more particularlynhuman embryo lung cells under conditionsndetermined, i.e. in an appropriate culture mediumnand in the presence of a stimulant like concanavalin A andnprotease inhibitors like aprotinin and / or bennzamidine, separation of the supernatant containing the activatorntissue plasminogen, isolation of the latter bynpurification and possibly its concentration. |
| priorityDate | 1983-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.